Diabetes News

Elevated blood HbA1c levels lead to an overestimation of SaO2 by SpO2, suggesting that arterial blood gas analysis may be needed for type 2 diabetic patients with poor glycemic control during the treatment of hypoxemia (Cardiovascular Diabetology)

Continuous glucose monitoring was associated with decreased HbA1c levels and time spent in hypoglycaemia in individuals with type 1 diabetes using CSII. More frequent self-adjustments of insulin therapy may have contributed to these effects (Diabetologia)

NIH-supported findings diverge from previous studies showing that blood sugar control benefits adults (National Heart, Lung, and Blood Institute)

The new fully-automated assay measures glycated hemoglobin (HbA1c), the recommended test to monitor diabetic patients in the laboratory (Abbott)

This study shows a significantly higher risk of abnormal MPI and CAD in diabetic patients with suboptimal and poor long-term glycemic control, further emphasizing the need for aggressive risk factor modification to minimize vascular complications from DM (Clinical Cardiology)

Review of the literature and implementation for practical use … Efficacy of CGM systems is now proven but indications, terms of use and educational issues of this new technology still need to be specified (Diabetes Research and Clinical Practice)

This prospective study showed that persons with lower HbA1c had better survival than those with higher HbA1c. The association was linear and independent of disease duration, type of medication use, and presence of co-morbidities. Any improvement of HbA1c appears to be associated with reduced mortality risk (PLoS ONE)

Random UAC >=14mg/l predicted cardiovascular events, diabetic nephropathy, and mortality just as well as ACR. UAC may be used to assess cardiovascular and renal risks in patients with type 2 diabetes (Journal of Diabetes and Its Complications)

This study documents the utility of C-reactive protein in predicting risk for all-cause mortality in European Americans with Type 2 diabetes and supports its use as a screening tool in risk prediction models (Diabetic Medicine)

The MY-Q is the first HRQoL questionnaire designed for use in clinical care. It has acceptable measurement properties and seems suitable for implementation in routine care of teenagers with diabetes (Pediatric Diabetes)

Demonstrating antiatherothrombotic properties of dipeptidyl peptidase-4 inhibitors on proven markers is of substantial clinical significance. Coupled with their proven good safety profile these findings could translate into a significant clinical benefit (Cardiovascular Diabetology)

This study demonstrated that home blood pressure telemonitoring combined with automated self-care support reduced the blood pressure of diabetic patients with uncontrolled systolic hypertension and improved hypertension control (Hypertension)

In 229 adults who met the inclusion criteria, after a mean follow-up period of 31 months, linear regression analysis showed no relationship between eGFR and BMI (Journal of Nephrology)